$NWBO @DCarnival46

#CancerMoonshot today will not only be about glioblastoma, but about the horrible DIPG (diffuse intrinsic pontine glioma) occuring in children and young adults.

You know who got their PIP plan approved last year by the MHRA in the UK? Image
You know who ANNOUNCED a new center of cancer excellence in Sutton in the UK two months ago, 130 miles from Sawston, focusing on DIPG? Image
You know who donated 2.5 million pounds to the center and that Hugh Adams works for them and have helped NWBO meeting british politicians and he wrote the "Pathway to a Cure" report, where politicians urges MHRA and NICE to get DCVax-L to patients? Image
SAME DAY MHRA announced this

"This new funding will accelerate the delivery of cutting-edge treatments like cancer vaccines" Image
One week later the MHRA announced this. Image
The new Quarterly SEC filing says

"We plan to work on preparations for Phase II trials of DCVax-Direct as resources permit."

You know NWBO already had planned DCVax-Direct trials in 2019 targeting DIPG?

nwbio.com/wp-content/upl… Image
Just saying.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with 🇩🇰 The Danish Dude 🇩🇰

🇩🇰 The Danish Dude 🇩🇰 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @FlemmingBruce

Jun 4
$NWBO

I asked ChatGBT, who is SIO Capital Management?

SIO Capital Management, LLC is a global equity market neutral healthcare hedge fund headquartered in New York. Founded by Dr. Michael Castor in 2006, the firm focuses exclusively on the healthcare sector ....
... which includes areas such as biotech, pharmaceuticals, medical devices, insurance, and hospitals. This specialization allows SIO to leverage its deep industry knowledge to identify investment opportunities and mispriced stocks within the complex healthcare landscape.
SIO Capital employs a balanced investment strategy aimed at both capital growth and preservation. Their approach includes rigorous financial analysis and a focus on catalysts that might drive stock performance.
Read 6 tweets
Apr 26
$NWBO

If you are STILL unaware, @SECGov and @GaryGensler are NOT a friend of "us".

Citadel and Virtu have built up an enormous liability post on their yearly financial condition statement, named

"Securities sold, not yet purchased at fair value”.

Essentially is is a ...
... way for market makers to "cover up" their cumulative short and distort scams and give it a "fair value".

Ranging from 45-65 billion dollars the last couple of years, the number is a placeholder for the destruction of companies, for layoff of employees, for preventing ....
... scientific breakthroughs, working treatments, vaccines and cures getting to people, to patients.

Ultimately it is how Wall Street has agreed to put a fair value on misery, deaths and sorrow.

It is a mechanism to make it possible for SEC and DTCC, to bury "fails to deliver".
Read 22 tweets
Apr 18
$NWBO

The Revimmune Connection

1) Northwest Biotherapeutics have a combination patent with DCVax-L and checkpoint inhibitors and Interleukin-7

2) Linda Powers is CEO of Northwest Biotherapeutics

3) Linda Powers owns Toucan Capital

4) Linda Powers is CEO of Advent Bioservices
5) Linda Powers is Director of Revimmune SAS

6) Linda Powers is Director of Revimmune Limited

7) Linda Powers was CEO of Cognate

8) Philippe Pire is CFO of Advent Bioservices

9) Philippe Pire is listed as employee at Revimmune Limited

10) J Kelly Ganjei is CEO of AmplifyBio
11) J. Kelly Ganjei was at Cognate

12) J. Kelly Ganjei was at Toucan Capital

13) Revimmune SAS is former Cytheris and changed its name in 2014 and is situated in France

14) Revimmune Limited is registered as a "dormant company" in the UK in 2020, one share for £1
Read 22 tweets
Feb 22
$NWBO

NO. I do NOT agree on low BO numbers, no matter WTF the number of outstanding/authorized share number count is.

Now I am talking to the rational and reasonable, who likes to take in the full picture of whats going on and doesn't go into cardiac arrest ...
... , whenever one of hedge funds lapdogs tweet or post todays about insanity theme.

This is about looking at whats been done, what is going on and then use simple logic to arrive at a conclusion by sheer reasoning.
With that in hand, lets look at some facts:

Who is at the helm?

Linda Powers is. Her resumé speaks for itself. Image
Read 21 tweets
Jan 5
$NWBO

The IRP procedure.



Look at the bottom:

"To further streamline the IRP application process, the MHRA launched an ‘Eligibility Checker’ tool on 20 November 2023."

Let's give that news a look shall we?gov.uk/government/new…
Once IRP is fully up-and-running in January, we will have created a further route for bringing new medicines to UK patients.

The launch is supported by £10m in funding from HM Treasury in March to support the development of the new recognition framework.

pharmatimes.com/news/mhra_laun…
And continues:

"The funding will be used to ACCELERATE ROUTES FOR BRINGING INNOVATIVE MEDICAL PRODUCTS DEVELOPED IN THE UK onto the market, as well as those made and approved by other trusted global regulatory partners."

You WILL notice TWO points are specified.
Read 9 tweets
Jan 4
$NWBO

This is Paul Milgrom.

In 2020, he was co-recipient of the Sveriges Riksbank Prize in Economic Sciences in Honor of Alfred Nobel “for improvements to auction theory and inventions of new auction formats.”

Safe to say. Mr. Milgrom is not stupid.

milgrom.people.stanford.edu
In the red corner we have @Dougielarge and his lapdog @Tiggersdad2, who consistenly have been claiming, that spoofing has no permanent impact to share price.

Being a paid shill and rendering his services to hedges/MMs instigating the spoofing of NWBO, his incentives are clear.
Let's look into the permanent damage of share price by spoofing. @hoffmann6383 have been great in finding not least Paul Milgroms words on the matter.

Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(